ADVENZYMES:NSE-Advanced Enzyme Technologies Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 398.85

Change

0.00 (0.00)%

Market Cap

INR 44.58B

Volume

0.18M

Avg Analyst Target

INR 434.67 (+8.98%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition; and enzymes for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications. It also provides non-food processing enzymes for textile processing, leather, pulp and paper, detergents and cleaning aids, bio-fuels, and biocatalysis. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India. Address: Sun Magnetica, Thane, India, 400604

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-24 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

N/A

INR2,957.93B 84.78 51.50
PIDILITIND:NSE Pidilite Industries Limited

N/A

INR1,172.11B 103.71 66.42
BERGEPAINT:NSE Berger Paints India Limited

N/A

INR829.87B 115.28 67.96
SRF:NSE SRF Limited

N/A

INR468.15B 38.44 22.25
KANSAINER:NSE Kansai Nerolac Paints Limited

N/A

INR336.31B 63.48 36.38
AARTIIND:NSE Aarti Industries Limited

N/A

INR322.97B 59.31 35.00
ATUL:NSE Atul Ltd

N/A

INR273.81B 38.95 25.57
SUMICHEM:NSE Sumitomo Chemical India Limite..

N/A

INR213.68B 61.86 41.40
ALKYLAMINE:NSE Alkyl Amines Chemicals Limited

N/A

INR205.85B 69.73 45.00
VINATIORGA:NSE Vinati Organics Limited

N/A

INR202.77B 74.25 53.10

ETFs Containing ADVENZYMES

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.46% 20% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.46% 17% F 29% F
Trailing 12 Months  
Capital Gain 145.82% 64% D 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 145.82% 64% D 69% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 12.60% 47% F 59% F
Dividend Return 0.18% 7% F 49% F
Total Return 12.79% 46% F 58% F
Risk Return Profile  
Volatility (Standard Deviation) 68.14% 29% F 30% F
Risk Adjusted Return 18.76% 41% F 52% F
Market Capitalization 44.58B 72% C- 72% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.52 42% F 40% F
Price/Book Ratio 4.60 37% F 23% F
Price / Cash Flow Ratio 27.37 36% F 20% F
EV/EBITDA 17.29 49% F 40% F
Management Effectiveness  
Return on Equity 15.96% 51% F 74% C
Return on Invested Capital 15.64% 70% C- 84% B
Return on Assets 12.16% 85% B 92% A-
Debt to Equity Ratio 1.02% 83% B 76% C
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.19 96% A 96% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector